1.25 Prescribed
Earlier Cancer Detection: The Growing Role of Cell-Free DNA (cfDNA) Blood Tests in Primary Care
by Med Learning Group
Credit available Fri 10/01/21 - Sat 10/01/22
Self-Study
for up to 1.25 Prescribed credits

This program will help learners improve their understanding of the latest in cancer biology with regard to cfDNA screening, methylation signatures and other aspects of early cancer detection. The program will address the benefits and limitations of current screening guidelines together with screening implications for emerging methods of early detection. Finally, the program will provide insight into the integration of cfDNA blood tests into clinical practice to help identify cancers earlier for
Learn moreContact Info
Name: Ana Maria Albino
Phone: 201-679-2906
Email: aalbino@medlearninggroup.com
Visit website
List of Sessions
Session Name | Date | Credits |
---|---|---|
Earlier Cancer Detection: The Growing Role of Cell-Free DNA (cfDNA) Blood Tests in Primary Care | Credit available Fri 10/01/21 - Sat 10/01/22 | 1.25 Prescribed credits |